| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/11/2004 | EP1444349A2 Process for the preparation of ramipril |
| 08/11/2004 | EP1444347A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs |
| 08/11/2004 | EP1444341A2 Rankl mimics and uses thereof |
| 08/11/2004 | EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444265A2 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 08/11/2004 | EP1444264A2 Methods and materials for targeting and affecting selected cells |
| 08/11/2004 | EP1444263A2 Method for improving stability of a bone-connecting implant |
| 08/11/2004 | EP1444256A2 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration |
| 08/11/2004 | EP1444255A2 Vesicle-associated proteins |
| 08/11/2004 | EP1444254A2 Molecules for disease detection and treatment |
| 08/11/2004 | EP1444253A2 Pna-conjugates for treating chronic myeloid leukemia (cml) |
| 08/11/2004 | EP1444252A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444194A1 N-methyl-homocystines, use thereof and method for the production thereof |
| 08/11/2004 | EP1443988A1 Device for and method of controlled enzymatic removal and retrieval of tissue |
| 08/11/2004 | EP1443972A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 08/11/2004 | EP1443971A2 METHOD OF USING 18080, A HUMAN SERINE CARBOXYPEPTIDASE FAMILY MEMBER |
| 08/11/2004 | EP1443965A1 Treatment of inflammatory conditions |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443955A1 Treatment of central nervous system disorders by use of pdgf or vegf |
| 08/11/2004 | EP1443954A2 Targeted thrombosis by tissue factor polypeptides |
| 08/11/2004 | EP1443953A2 Detection and treatment of intravascular lesions |
| 08/11/2004 | EP1443952A2 A method of reducing mortality and morbidity associated with critical illnesses |
| 08/11/2004 | EP1443951A2 Molecular interactions in cells |
| 08/11/2004 | EP1443950A2 A plant extract active as an immunostimulating agent |
| 08/11/2004 | EP1443947A1 Use of defibrinated blood for the manufacture of a hemoglobin-based oxygen carrier |
| 08/11/2004 | EP1443941A2 Agents for treating lesions of the nervous system |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443933A2 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
| 08/11/2004 | EP1443932A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 08/11/2004 | EP1443922A1 Mch antagonists for the treatment of obesity |
| 08/11/2004 | EP1443919A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443907A1 Biocompatible polymer blends and uses thereof |
| 08/11/2004 | EP1443905A2 Compositions for oral gene therapy and methods of using same |
| 08/11/2004 | EP1443904A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel |
| 08/11/2004 | EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 08/11/2004 | EP1443860A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 08/11/2004 | EP1443818A2 Novel secreted proteins and their uses |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1379278A4 Method of inducing proliferation of retinal stem cells |
| 08/11/2004 | EP1363677A4 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/11/2004 | EP1351977B1 Antimicrobial pseudopeptides |
| 08/11/2004 | EP1282638A4 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 08/11/2004 | EP1272044B1 Protein stabilised emulsions |
| 08/11/2004 | EP1246641B1 Bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 08/11/2004 | EP1140918B1 Thrombin inhibitors |
| 08/11/2004 | EP1051187B9 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
| 08/11/2004 | EP1028991B1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/11/2004 | EP1028774B1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 08/11/2004 | EP1012329A4 Diagnosis and treatment of myocardial failure |
| 08/11/2004 | EP1003776B1 Screening method using FREAC-11 transcription factor |
| 08/11/2004 | EP0977859B1 The neurotrophic factor nnt-1 |
| 08/11/2004 | EP0894135B1 Multivalent and multispecific antigen-binding protein |
| 08/11/2004 | EP0869811B1 Immunologically active mistletoe extract preparations |
| 08/11/2004 | EP0867450B1 TFPI-related Peptides which inhibit growth of smooth muscle cells |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | EP0832101B1 Urethane mediated, gst specific molecular release systems |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0779922B1 Modified human c3 proteins |
| 08/11/2004 | EP0749472B1 Extracorporeal cell culture and transplantation kits |
| 08/11/2004 | EP0730648B1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 08/11/2004 | EP0629132B1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 08/11/2004 | EP0604560B1 Human cyclin e |
| 08/11/2004 | EP0575464B1 Modified factor vii |
| 08/11/2004 | CN1520422A Anti-obesity polypeptides |
| 08/11/2004 | CN1520421A Recombinant tumor specific antibody and use thereof |
| 08/11/2004 | CN1520401A Calcilytic compounds |
| 08/11/2004 | CN1520312A T cell induced tissue repair and regeneration |
| 08/11/2004 | CN1520310A Use of angiotensin derivative as agent for treatment and prevention of infarction-related cardiac injuries and disorders |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520303A Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1520259A Method to treat hemophilia by hepatic gene transfer of factor VIII/IX with vesicle vector |
| 08/11/2004 | CN1519023A Iso saponin capsule of superoxide dismutase |
| 08/11/2004 | CN1519022A Gelling agent of stimulating factor of macrophage colony of recombined human granular leudocytes and preparation method |
| 08/11/2004 | CN1519021A Stable erythropoietin of recombined human red blood cell |
| 08/11/2004 | CN1519020A Combined medication of reduction typed glutathione and selenium compound |
| 08/11/2004 | CN1161615C Time for predicting taking out of non-fertilisable ova, its method and application |
| 08/11/2004 | CN1161469C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 08/11/2004 | CN1161468C MPL ligand analogs |
| 08/11/2004 | CN1161467C Fusion protein with function of resisting tumor and its application |
| 08/11/2004 | CN1161465C Chimeric proteins for use in transport of selected substance into cells |
| 08/11/2004 | CN1161464C Human epidermal growth factor recetor specitic fusion protein and its application |
| 08/11/2004 | CN1161396C Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties |
| 08/11/2004 | CN1161382C Production of recombination human lactoferritin |
| 08/11/2004 | CN1161381C Gonadotropins with non-native disulfide bridges |
| 08/11/2004 | CN1161379C Novel peptides derived from autoantigent for use in immunitherapy of autoimmune diseases |
| 08/11/2004 | CN1161378C Antitumour polypeptide and gene therapy vector composition |
| 08/11/2004 | CN1161377C Giant web bombinator skin peptide and its prepn. and pharmaceutical application |
| 08/11/2004 | CN1161375C Fusion protein with improved combining activity to target cell receptor |
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161373C Peptide and method for obtg. same |
| 08/11/2004 | CN1161372C Novel peptide having biological activity |
| 08/11/2004 | CN1161371C Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |